Table S3.
EPAP | Sham | |
---|---|---|
N = 19/119 (16.0%) | N = 15/110 (13.6%) | |
Lost to follow-up | 2 | 5 |
Device-related adverse events | ||
Dry mouth/throat | 3 | |
Breathing discomfort | 2 | |
Nasal itching | 1 | |
Sleep maintenance insomnia | 1 | |
Vertigo | 1 | |
Oxygen desaturation | 1 | |
Adverse events not device related | ||
Tonsil infection | 1 | |
Transient ischemic attack | 1 | |
Severe degenerative disc disease and neuropathic pain | 1 | |
Unable to acclimate to device | 1 | 1 |
Patient non-compliant with protocol | ||
Due to study assessment requirements | 2 | |
Unwilling to do last 2 PSGs | 1 | |
Missed month 3 office visit | 1 | 1 |
Patient using CPAP | 1 | |
Site protocol deviation | ||
Violation of study entry criteria | 2 | |
Patient prefers alternative treatment | 2 | |
Other | ||
Patient not allowed on hospital property | 1 | |
Patient personal emergency | 1 | |
Site withdrawal from study (staff lay-offs) | 1 |
EPAP vs sham dropout rate P = 0.62.